Your browser doesn't support javascript.
loading
Methods for Stratification and Validation Cohorts: A Scoping Review.
Torres Moral, Teresa; Sanchez-Niubo, Albert; Monistrol-Mula, Anna; Gerardi, Chiara; Banzi, Rita; Garcia, Paula; Demotes-Mainard, Jacques; Haro, Josep Maria.
Afiliação
  • Torres Moral T; Research and Development Unit, Parc Sanitari Sant Joan de Déu, 08830 Barcelona, Spain.
  • Sanchez-Niubo A; Melanoma Unit, Dermatology Department, August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and Hospital Clínic, 08036 Barcelona, Spain.
  • Monistrol-Mula A; Center for Networked Biomedical Research on Rare Diseases (CIBERER), Carlos III Health Institute, 28029 Madrid, Spain.
  • Gerardi C; Research and Development Unit, Parc Sanitari Sant Joan de Déu, 08830 Barcelona, Spain.
  • Banzi R; Center for Networked Biomedical Research on Mental Health (CIBERSAM), Carlos III Health Institute, 28029 Madrid, Spain.
  • Garcia P; Department of Social Psychology and Quantitative Psychology, University of Barcelona, 08028 Barcelona, Spain.
  • Demotes-Mainard J; Research and Development Unit, Parc Sanitari Sant Joan de Déu, 08830 Barcelona, Spain.
  • Haro JM; Centre for Health Regulatory Policies, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.
  • The Permit Group; Centre for Health Regulatory Policies, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.
J Pers Med ; 12(5)2022 Apr 26.
Article em En | MEDLINE | ID: mdl-35629113
ABSTRACT
Personalized medicine requires large cohorts for patient stratification and validation of patient clustering. However, standards and harmonized practices on the methods and tools to be used for the design and management of cohorts in personalized medicine remain to be defined. This study aims to describe the current state-of-the-art in this area. A scoping review was conducted searching in PubMed, EMBASE, Web of Science, Psycinfo and Cochrane Library for reviews about tools and methods related to cohorts used in personalized medicine. The search focused on cancer, stroke and Alzheimer's disease and was limited to reports in English, French, German, Italian and Spanish published from 2005 to April 2020. The screening process was reported through a PRISMA flowchart. Fifty reviews were included, mostly including information about how data were generated (25/50) and about tools used for data management and analysis (24/50). No direct information was found about the quality of data and the requirements to monitor associated clinical data. A scarcity of information and standards was found in specific areas such as sample size calculation. With this information, comprehensive guidelines could be developed in the future to improve the reproducibility and robustness in the design and management of cohorts in personalized medicine studies.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Ano de publicação: 2022 Tipo de documento: Article